Navigation Links
Antibodies from plants protect against anthrax

Scientists have produced, in tobacco plants, human antibodies that could be used to treat anthrax exposure. They report their findings today at the 2005 American Society for Microbiology Biodefense Research Meeting.

"The nature of bioterrorism is such that an aggressor is likely to strike at a time and place calculated to induce maximum terror through mass casualties. The unpredictable nature of such events compels us to develop cost-effective, highly stable medical countermeasures to enable authorities to treat individuals exposed to bioterror agents such as anthrax," says Les Baillie of the Naval Medical Research Center. Dr. Baillie, who is also associated with the University of Maryland Biotechnology Institute, conducted his research in collaboration with Dr. Vidadi Yusibov, Director of the Fraunhofer USA Center for Molecular Biotechnology (CMB) in Newark, Delaware. Funding for this project at the Fraunhofer USA CMB was obtained through the efforts of a congressional delegation lead by Delaware's Senior Senator Joe Biden.

To create the "plantibodies," Baillie and his colleagues first collected the cells that make antibodies from individuals who had been vaccinated against anthrax. Then genes that encode the antibody itself were inserted into a bacterium that transfers the gene into the plant cells. "The plant makes the antibody for you in a few days," says Baillie.

The antibodies were then purified from leaves harvested from the infected plants and tested for their ability to protect mice against anthrax infection. The plant-produced antibodies were just as effective as the antibodies produced by human cells from immunized individuals.

The antibodies can be used either before exposure to prevent infection or after exposure as treatment.

"If you've been exposed to an agent, you want protection as soon as possible. Vaccination can take a very long time to build immunity. Antibodies give you immediate protection," says Baillie.

"Plant-produced antibodies are also safer because there is no risk of contamination by human or animal pathogens, and plant viruses are not known to infect humans," says Yusibov.

"It is an easy, inexpensive and, very stable system. If you're looking for a way to stockpile a large amount of antibodies for a long periods of time, plant-produced antibodies are the answer," says Baillie.

Anthrax antibodies are just the first step for Baillie and his collaborators. Plantibodies against the plague bacterium and botulism are also in development.


'"/>

Source:American Society for Microbiology


Related biology news :

1. Emory Eye Center Implants Its First Retinal Chips In Patients With Retinitis Pigmentosa
2. New RNA polymerase discovered in plants
3. Transgenic plants remove more selenium from polluted soil than wild plants, new tests show
4. Scientists discover how plants disarm the toxic effects of excessive sunlight
5. Defenseless plants arm themselves with metals
6. At long last, scientists figure out how plants grow
7. Precise Timing Enabled Pig-to-rat Transplants To Cure Diabetes
8. Engineers improve plastics potential for use in implants by linking it to biological material
9. Innovative coating could give medical implants a longer life
10. Mechanism for the captation of nutrients in plants- unknown to date
11. Its electric: Cows show promise as powerplants
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/22/2016)... DUBLIN , January 22, 2016 ... has announced the addition of the  ... to their offering. --> ... of the  "Global Behavioral Biometric Market ... --> Research and Markets ( http://www.researchandmarkets.com/research/4lmf2s/global_behavioral ...
(Date:1/20/2016)... , Jan. 20, 2016 A market ... to directly benefit from the explosion in genomics knowledge. ... Howe Sound Research. A range of dynamic trends are ... - personalized medicine - pharmacogenomics - pathogen evolution ... with large markets - greater understanding of the role ...
(Date:1/18/2016)... , Jan. 18, 2016  Extenua Inc., ... that simplifies the use and access of ubiquitous ... go-to-market partnership with American Cyber.  ... extensive experience leading transformational C4ISR and Cyber initiatives ... integrating the latest proven technology solutions," said ...
Breaking Biology News(10 mins):
(Date:2/10/2016)... Ky. , Feb. 10, 2016 NX ... utilizing its proprietary NeXosome® technology for early warning ... of its most recent study by Dr. ... at the Society for Maternal Fetal Medicine,s (SMFM) annual ... GA, February 1-6 th , 2016.  The presentation reported ...
(Date:2/10/2016)... York, New York (PRWEB) , ... ... ... Pharmaceuticals Inc. (NASDAQ: REGN) today announced that it has joined the Human ... and immunotherapies for infectious diseases and cancer. , The Human Vaccines ...
(Date:2/10/2016)... plc (NYSE: AGN ) a leading global pharmaceutical ... CEO and President, will be featured as the keynote ... Capital Markets Healthcare Conference on Tuesday, February 23, 2016 ... Hotel in New York, NY . ... accessed on Allergan,s Investor Relations web site at ...
(Date:2/10/2016)... ... February 10, 2016 , ... Benchmark Research, a ... promotion of two long-standing principal investigators (PI) to the roles of Chief Medical ... Development. , Dr. Laurence Chu, a Benchmark Research PI in the Austin office, ...
Breaking Biology Technology: